Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urothelial Carcinoma of the Urinary Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05312671
What this trial is testing

Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer

Who this might be right for
Small Cell Neuroendocrine Carcinoma of BladderBladder CancerUrothelial Carcinoma Bladder
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 63
Very early researchActive Not RecruitingNCT03837821
What this trial is testing

(CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer

Who this might be right for
Bladder Cancer
Weill Medical College of Cornell University 20
Testing effectiveness (Phase 2)Study completedNCT00045630
What this trial is testing

S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
SWOG Cancer Research Network 77
Testing effectiveness (Phase 2)Study completedNCT00002914
What this trial is testing

Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Eastern Cooperative Oncology Group 40
Testing effectiveness (Phase 2)WithdrawnNCT05687721
What this trial is testing

Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder Cancer

Who this might be right for
Advanced Urothelial Carcinoma
VA Office of Research and Development
Not applicableUnknownNCT04339933
What this trial is testing

Detection of FGFR Gene Mutations in the Tumor Tissue and Urine of Patients With Urothelial Carcinoma

Who this might be right for
Bladder Cancer
Ho Kyung Seo 92
Not applicableEnded earlyNCT02027649
What this trial is testing

Detection of K14 in Bladder Cancer With a Non Invasive Technique

Who this might be right for
Bladder Cancer
Corporacion Parc Tauli 400
Testing effectiveness (Phase 2)Ended earlyNCT02316548
What this trial is testing

Surgery With or Without Postoperative Intensity Modulated Radiation Therapy in Treating Patients With Urothelial Bladder Cancer

Who this might be right for
Stage III Bladder CancerStage IV Bladder Cancer
NRG Oncology 14
Not applicableUnknownNCT04718948
What this trial is testing

Multimodal Spectroscopy to Detect Urothelial Cancer in Urine

Who this might be right for
Urothelial CarcinomaUrinary Bladder CancerUrinary Tract Cancer
University of Florence 500
Testing effectiveness (Phase 2)Study completedNCT01373294
What this trial is testing

Oral Lenalidomide and Intravesical BCG for Therapy of Bladder Cancer

Who this might be right for
Bladder Cancer
H. Lee Moffitt Cancer Center and Research Institute 17
Testing effectiveness (Phase 2)Study completedNCT00003129
What this trial is testing

Chemotherapy in Treating Patients With Early-Stage Bladder Cancer

Who this might be right for
Bladder Cancer
Eastern Cooperative Oncology Group 75
Not applicableLooking for participantsNCT06349642
What this trial is testing

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

Who this might be right for
Early Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Cervical Carcinoma+24 more
Mayo Clinic 324
Early research (Phase 1)Active Not RecruitingNCT04459273
What this trial is testing

Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers

Who this might be right for
Bladder CarcinomaCervical CarcinomaCholangiocarcinoma+13 more
Jonsson Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00004203
What this trial is testing

Oxaliplatin in Treating Patients With Metastatic Bladder Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
University of Chicago 20
Not applicableLooking for participantsNCT07589413
What this trial is testing

Association Between Irrigation Fluid Absorption and Perioperative cfDNA Dynamics After TURBT

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerBladder Cancer RecurrenceProgression of Bladder Cancer+2 more
Zhiping Wang 150
Testing effectiveness (Phase 2)Study completedNCT00981656
What this trial is testing

Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer

Who this might be right for
Bladder Cancer
Radiation Therapy Oncology Group 37
Testing effectiveness (Phase 2)Looking for participantsNCT07186842
What this trial is testing

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

Who this might be right for
Advanced Solid Cancers
BioNTech SE 245
Testing effectiveness (Phase 2)Looking for participantsNCT03866382
What this trial is testing

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Who this might be right for
Bladder AdenocarcinomaBladder Clear Cell AdenocarcinomaBladder Mixed Adenocarcinoma+42 more
National Cancer Institute (NCI) 314
Testing effectiveness (Phase 2)UnknownNCT01196403
What this trial is testing

Standard Surgery or Minimal-Access Surgery in Treating Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
Wales Cancer Trials Unit 92
Testing effectiveness (Phase 2)Looking for participantsNCT06161532
What this trial is testing

Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...

Who this might be right for
Small Cell Carcinoma of the BladderSmall Cell Carcinoma of the Urinary TractSquamous Cell Carcinoma of the Bladder+5 more
National Cancer Institute (NCI)
Next Page
60